Multiplexed-50 cfDNA Standard at 3%AF, 1ug in TE

A 1 µg multiplexed cfDNA standard containing a panel of 50 clinically relevant somatic mutations, each present at a 3% allele frequency (AF). This highly characterized material is suspended in TE buffer for stability.

Designed for the validation and routine monitoring of next-generation sequencing (NGS)-based oncology assays. It is used to verify the detection of multiple mutations simultaneously, confirm allele frequency sensitivity, and assess the overall performance of bioinformatics pipelines.

Store at -20°C or below. This reference standard provides a powerful tool for assay optimization and ensures the accuracy and reliability of multiplexed cancer panels.